Senior Lecturer Outi Salo-Ahen is affiliated with Åbo Akademi University's Faculty of Natural Sciences and Engineering , Department of Pharmacy. Her research focuses on computational pharmacology, drug design, and pharmaceutical chemistry, particularly targeting chemokine receptors (CCR5/CXCR4) and transient receptor potential channels (TRPA1) for therapeutic applications. Doctor of Pharmacy (2006, University of Kuopio/UEF) MSc in Pharmaceutical Chemistry (2001, UEF) BSc in Pharmacy (1999, UEF) University Pedagogy Modules 1-5 (2012-2015) Her work contributes to UN Sustainable Development Goals through education and pharmaceutical innovation . Recent research trends include: Antimicrobial resistance solutions TRPA1 channel modulation Nanotechnology-enabled drug delivery Multi-target HIV-1 inhibitors 3D printing of biocompatible materials Computational analysis of nucleic acid frameworks She actively supervises doctoral projects, serves on assessment panels, and leads collaborations like Nordic Pharmaceutical Translation and Innovation. Her 60+ publications demonstrate expertise in molecular modeling and drug discovery.
Jouni Hirvonen is a Professor in the Division of Pharmaceutical Chemistry and Technology at the University of Helsinki's Faculty of Pharmacy. He serves as Supervisor for doctoral programmes in both the Doctoral Programme in Drug Research and the Doctoral Programme in Materials Research and Nanosciences. With an extensive publication record spanning over three decades, Hirvonen has contributed 384 research outputs and participated in 3 major research projects. His research interests focus on pharmaceutical technology, particularly in drug delivery systems, nanoparticles, and drug dissolution and absorption. His work bridges pharmaceutical chemistry with cutting-edge nanotechnology applications, developing innovative delivery systems for therapeutic agents. His research spans from fundamental pharmaceutical sciences to translational applications in regenerative medicine, immunotherapy, and cardiovascular pharmacology. The analysis of his recent publications reveals a strong focus on advanced drug delivery platforms, particularly utilizing nanoparticles, lipid-based systems, and biomaterials for targeted delivery. His work increasingly integrates microfluidic technology for precise nanoparticle preparation, with applications spanning cancer immunotherapy, cardiovascular repair, tendon regeneration, and inflammatory disease treatment. The trend shows a growing emphasis on combination therapies, RNA delivery, and cell-mediated drug delivery approaches. Hirvonen has received several prestigious awards throughout his career: CRS/Eurand Grand Prize Award on Innovations in Oral Drug Delivery Technologies (2007) Suomen Valkoisen Ruusun Ritarikunnan I luokan ritarimerkki (2013) The Young Scientist in the University of Kuopio (1993) University of Helsinki Quality Teaching Unit, Faculty of Pharmacy (2005) Visiting Professor award (2015) With 25 instances of supervising doctoral theses and numerous academic activities including conference organization, committee memberships, and editorial work, Hirvonen has made significant contributions to academic mentorship and institutional development. His research has been supported by projects including Generation Green, 3i REGENERATION, and IVIVRe. His work appears to involve collaboration with multiple research teams focusing on drug delivery applications across various therapeutic areas.
Samuli Ripatti is a Professor of Biometry at the Faculty of Medicine, University of Helsinki, and Director of the Institute for Molecular Medicine Finland (FIMM). He chairs the Research Council Finland’s Centre of Excellence in Complex Disease Genetics and the EU H2020-funded Intervene Consortium. His research focuses on genetic variation in the Finnish population, particularly its effects on cardiometabolic diseases and cancers, with a strong emphasis on polygenic risk scores for disease prevention and early detection. His work spans Genetic risk prediction models Lipidomic and metabolomic profiling Gene-environment interactions Translational genomics Recent research highlights include 1099 plasma metabolite-disease causal analysis Genetic determinants of weight loss interventions Cardiovascular risk stratification tools Leukocyte lipid metabolism pathways He actively supervises doctoral programs in Integrative Life Science, Social Sciences, Clinical Research, and Population Health, and collaborates with the Broad Institute of MIT and Harvard.
Anja Rantanen is a University Lecturer at Tampere University's Faculty of Social Sciences and Health Sciences, specializing in Nursing Science. She teaches nursing at bachelor's and master's levels and supervises theses and dissertations. PhD in Nursing Science Adjunct Professor in Nursing Science Her research focuses on quality of life and psychosocial support for adult families, with recent work examining strabismus patients' experiences and inflammatory bowel disease nursing care. She employs qualitative and cross-sectional methodologies, emphasizing patient-centered care and healthcare quality assessment. Recent publications analyze strabismus-related HRQOL in Finland and psychosocial support expectations from healthcare professionals. These studies highlight intersections between nursing science, ophthalmology, and health services research. She serves as a doctoral thesis supervisor, conference reviewer, and pre-examiner for dissertation committees.
Seamus Martin is a Professor affiliated with Trinity College Dublin, Ireland. He was recently hosted as an academic visitor at Åbo Akademi University under the InFLAMES Research Flagship, which focuses on immune system-based innovation. His visit, hosted by Dr. A. Meinander, took place from November 29 to December 1, 2024, indicating active engagement in collaborative immunological research. His research interests center on immunology and molecular mechanisms of disease, particularly in the context of inflammation and cell biology. The context of a doctoral thesis on intestinal inflammation and a FEBS journal article link suggest a strong focus on biochemical and cellular pathways involved in inflammatory responses, particularly in the gastrointestinal system. No recent publications, awards, or advising activities were explicitly mentioned in the provided text. However, his designation as a professor and involvement in high-level research collaborations reflect a significant academic standing in the field of immunology and cell biology.
Professor Pipsa Saharinen is a faculty member at the University of Helsinki, affiliated with the Department of Biochemistry and Developmental Biology within the Faculty of Medicine . Her research focuses on vascular biology, lymphatic system dynamics, and cancer therapy, particularly investigating mechanisms regulating endothelial cell behavior and vascular integrity. She holds grants from the Sigrid Jusélius Foundation, Cancer Foundation (Syöpäsäätiö), and the Academy of Finland, supporting projects like Biological Barrier Mechanics and Disease and Translational Cancer Medicine Program . Her work includes collaborations in the Helsinki In Vivo Animal Imaging Platform , enhancing translational research capabilities. Her scientific contributions span over 75 publications, emphasizing vascular mechanotransduction, lymphangiogenesis, and targeted therapies for metastatic cancers. Key findings include cytoskeletal regulation in lymphatic endothelium resilience and the protective role of Pim3 kinase in vascular barriers. Awards: Pfizer Scholar in Cancer Research (2001), Best Biomedical Thesis (2004) Supervised: Postdoctoral researchers (e.g., Anne Pink, Elina Kiss) and doctoral candidates in biomedical and integrative life sciences. Current research explores molecular mechanisms underlying vascular barrier function and metastasis, with clinical implications for cancer treatment and lymphatic disorders.
Reetta Satokari is a University researcher and Researcher at the Department of Microbiology and Biotechnology, University of Helsinki. She serves as a supervisor in multiple doctoral programmes including Human Microbiome Research, Drug Research, Biomedicine, Clinical Research, Clinical Veterinary Medicine, Food Chain and Health, and Microbiology and Biotechnology. Her research focuses on microbiota dynamics, fecal microbiota transplantation (FMT), antibiotic resistance, probiotics, and gastrointestinal health. She leads the EU Horizon Europe project ENDOTARGET (2023-2026) and has contributed to over 100 peer-reviewed articles. Notable work includes studies on FMT efficacy in Parkinson's disease and chronic pouchitis, and the prolonged effects of antibiotics on gut microbiota. Her scientific accolades include the Nutrients 2020 Best Paper Award. She actively participates in conferences, media interviews, and thesis supervision. Projects include investigating fetal intestinal microbiota's role in immune development and advancing FMT safety protocols. Her work bridges microbiology, immunology, and clinical applications, with a focus on translational therapies for gastrointestinal and neurodegenerative disorders.
Päivi Rajala-Schultz is a Professor in the Department of Production Animal Medicine within the Faculty of Veterinary Medicine at the University of Helsinki. She serves as Supervisor for the Doctoral Programme in Clinical Veterinary Medicine and is affiliated with Helsinki One Health (HOH). Her research focuses on ruminant health and animal reproduction science, with particular expertise in dairy cattle health management. PhD from Cornell University (1994-1998) Diplomate of American College of Veterinary Preventive Medicine (2008) Former faculty member at The Ohio State University (1999-2015) Professor Rajala-Schultz's research interests span veterinary epidemiology, mastitis management, dry cow therapy, and antimicrobial stewardship in dairy production. Her work emphasizes evidence-based approaches to improve dairy cattle health while promoting responsible antibiotic use. She has been instrumental in developing Nordic guidelines for mastitis therapy and has conducted extensive research on selective dry cow therapy as an alternative to blanket treatment. Analysis of her recent publications (2021-2025) reveals a strong focus on dairy cattle udder health, with particular emphasis on selective dry cow therapy, mastitis prevention strategies, and the relationship between management practices and animal health outcomes. Her research spans both clinical field trials and epidemiological studies, often incorporating economic perspectives on veterinary interventions. Recent work has expanded to examine digital dermatitis, social hierarchy in dairy herds, and systemic inflammation markers. Diplomate of American College of Veterinary Preventive Medicine (2008) Professor Rajala-Schultz actively supervises graduate students, including Saara Soikkanen's Master's thesis in 2023. She manages multiple research projects, including 'Überis yhteistyö' (2025-2028) funded by Valio Oy, 'ÜBERIS_tutkimusyhteistyö' (2024-2028) funded by Vetcare Oy, and 'Uberis: Streptococcus uberis' (2024-2028) funded by the Ministry of Agriculture and Forestry. Her research has been supported by both corporate and governmental funding sources, reflecting the practical application of her work in the dairy industry. She manages the Farm Animal Research Laboratory of the Saari Unit, which supports her research on production animal medicine. Professor Rajala-Schultz is actively involved in Nordic collaborative research on mastitis and has presented her work at numerous international conferences, contributing to the development of evidence-based guidelines for dairy cattle health management across Europe.
Ali Abdollahzadeh is an Academy Research Fellow at the A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, within the Faculty of Health Sciences. His research focuses on medical image analysis and biophysics, particularly in neuroimaging techniques like diffusion MRI and electron microscopy. He develops advanced computational tools for analyzing white matter ultrastructures and neurovascular interactions. Key projects include studying the role of meningeal lymphatics in neuroinflammation and migraine mechanisms, as well as creating open-source software like SproutAngio and gACSON for bioimage informatics. His work bridges biophysics, computational neuroscience, and clinical applications. Recent studies explore axonal remodeling under stress, neurovascular dynamics, and deep learning applications in neurological disease analysis. He collaborates with the Computational Neuroanatomy Lab and Multiscale Imaging Group, advancing interdisciplinary research in brain imaging and neurodegenerative disorders. Publications highlight innovations in segmentation algorithms, 3D imaging techniques, and translational studies linking microscopic findings to clinical outcomes. His research aims to enhance understanding of CNS structure-function relationships and improve diagnostic tools through advanced imaging methodologies.
Hanna Ruhanen is a researcher affiliated with the Functional Lipidomics Group at the University of Helsinki , specializing in lipidomics and its intersections with genetics, physiology, and environmental biology. She contributes to advanced research on lipid profiles in diverse contexts, including human disease and marine ecosystems. Research Interests: Lipidomics and proteomics of high-density lipoprotein (HDL) Genetic and environmental influences on lipid metabolism Ecological lipid studies in marine organisms Recent Publications span lipid profiling in systemic lupus erythematosus , menopause-related cardiovascular changes, and dietary variability in copepods, reflecting her interdisciplinary focus on lipid dynamics across biological systems. Labs & Teams: She is a key operator in the Helsinki University Lipidomics Unit , collaborating on functional omics projects and ecological lipidomics.
Per-Henrik Groop serves as Research Director at the Department of Medicine Research Programs Unit, University of Helsinki, holding the title of Docent at Clinicum. He is actively involved as Supervisor for multiple doctoral programs including the Doctoral Programme in Biomedicine, Doctoral Programme in Clinical Research, and Doctoral Programme in Population Health. Affiliated with the HUS Abdominal Center, Dr. Groop has established himself as a leading international researcher in diabetes and its complications with an impressive publication record of 529 research outputs. Dr. Groop's research program focuses on understanding why only a subset of patients with diabetes develop serious complications, with particular emphasis on diabetic nephropathy, cardiovascular complications in type 1 diabetes, and the genetic determinants of these conditions. His work bridges clinical medicine with advanced genetic and molecular research approaches, often utilizing large cohort studies to identify risk factors and potential therapeutic targets. A significant portion of his research examines the interplay between genetic susceptibility and environmental factors in the development of diabetic complications. Analysis of Dr. Groop's recent publication trend reveals a continued strong focus on the mechanisms behind diabetic kidney disease and cardiovascular complications. His work spans from basic science investigations using animal models to large-scale clinical studies examining multiple organ systems affected by diabetes. A notable emphasis in his recent work is the examination of cumulative exposures to hyperglycemia and dyslipidemia and their long-term effects on organ damage in type 1 diabetes patients, with implications for clinical management strategies. Cunningham Lecture in Integrative Physiology: Diabetic complications – are they acquired or inherited? (2008) EASD Castelli Pedroli Prize – 24th Camillo Golgi Lecture: Diabetic nephropathy – means, motive and opportunity (2009) Kimmelstiel-Wilson Lecture: Baker IDI & George Institute Symposium, Diabetic nephropathy – an acquired or inherited diabetic complication? (2010) Novo Nordisk Foundation Lecture Award: Why does a subset of patients with diabetes develop kidney disease? (2012) Emil R. Rosenqvist's Prize (2013) Dr. Groop has supervised numerous doctoral students across multiple programs at the University of Helsinki, with a focus on type 1 diabetes complications, genetic factors in diabetes, and obesity-related complications. His supervision includes serving as primary supervisor or co-supervisor for doctoral theses on topics such as cerebral small vessel disease in type 1 diabetes, genetic and metabolomic factors of diabetic kidney disease, and obesity complications in type 1 diabetes. He is actively involved in significant research projects including the IMI2 Beat DKD project, which focuses on advancing understanding and treatment of diabetic kidney disease. Dr. Groop leads research activities at the HUS Abdominal Center in Helsinki and maintains extensive collaborations with researchers across Finland and internationally. His research group focuses on understanding the mechanisms behind diabetic complications, particularly nephropathy and cardiovascular disease, with the ultimate goal of developing better prevention strategies and personalized treatment approaches for patients with diabetes.
Koen Van Leemput is a Professor at the Department of Neuroscience and Biomedical Engineering at Aalto University, Finland. His work bridges neuroscience and computer science , focusing on generative models , magnetic resonance imaging (MRI) , and machine learning applications in neurodegenerative diseases like Alzheimer's Disease and Multiple Sclerosis (MS) . Research Highlights: Development of interpretable AI models for subject-level prediction in neuroimaging. Advancements in uncertainty quantification for neuroimage registration. Leadership in the CLAIMS project , creating AI-driven prognostic models for MS progression. Pioneering MRI intensity scaling techniques to improve quantitative imaging reliability. Scientific Contributions: Editorial Roles: Served on the board of IEEE Transactions on Medical Imaging and Medical Image Analysis (2014). Collaborations: Includes affiliations with Harvard Medical School and Technical University of Denmark (DTU).
Hani El-Nezamy is a Professor at the Institute of Public Health and Clinical Nutrition , part of the School of Medicine at the University of Eastern Finland . His research focuses on gut health, microbial therapy for liver diseases, and food safety through microbiota modulation. Key Research Areas : Gut microbiota interactions, probiotic applications, mycotoxin mitigation, liver disease management, and nanoparticle toxicology Notable Collaborators : Emily Kwun Kwan Lo, Congjia Chen, Marsena Jasiel Ismaiah, Fangfei Zhang His 15 most recent publications (2023-2025) demonstrate expertise in probiotic interventions for metabolic and liver diseases, mycotoxin effects on gut epithelium, engineered microbial therapies, and interactions between dietary compounds and gut microbiota. Articles span disciplines including hepatology, microbiome research, toxicology, nutritional biochemistry, and pharmacology. Current research projects include investigating engineered bacteria for metabolic diseases, analyzing microplastic effects on gut health, and developing probiotic adjuvants for cancer therapy. His work frequently employs mouse models , metagenomic analysis , and microbial engineering techniques.
Ninja Karikoski is a Senior Clinical Instructor at the University of Helsinki within the Faculty of Veterinary Medicine , specifically the Department of Equine and Small Animal Medicine . With a focus on Equine Endocrinology , Karikoski's research explores insulin dysregulation, metabolic disorders, and pharmacological interventions in horses. Key Research Areas: Equine Endocrinology, Clinical Pharmacology, Comparative Genetics, Animal Physiology, Equine Internal Medicine Karikoski's recent publications analyze the effects of alpha-2 adrenergic agents on equine metabolism, genetic loci linked to insulin dysregulation and insect bite hypersensitivity, and bedding material impacts on respiratory health. Collaborations span institutions like Eläinlääketieteen tutkimuksen tukisäätiö and Suomen Hippos ry. Supervision: Directed doctoral theses on equine diabetes (Justin Box), equine ophthalmology (Katri Kosunen), and hoof pathology (Paula Jaakkola). Projects under Karikoski’s leadership include genetic studies of Finnhorses and metabolic health initiatives. Teaching activities emphasize clinical veterinary pedagogy and diagnostic methods.
Alexander Aaronson is a researcher at the University of Helsinki, affiliated with the HUS Head and Neck Center. His work focuses on ophthalmology, particularly complications associated with cataract surgery and their management. Ophthalmology Cataract Surgery Macular Edema Intraocular Inflammation Diabetic Eye Disease Postoperative Complications Aaronson's research examines the interplay between intraocular inflammation and macular edema following cataract procedures, the impact of surgical experience on complication rates, and the efficacy of preoperative anti-inflammatory treatments in diabetic patients. His studies aim to refine postoperative care protocols and improve patient outcomes. His recent publications highlight trends in cataract surgery complications, the clinical course of cystoid macular edema treated with nepafenac, and the role of inflammation in pseudophakic conditions. These works span disciplines such as ophthalmology, pharmacology, and diabetes management.
